封面
市場調查報告書
商品編碼
1619229

微陣列市場規模、佔有率、成長分析,按產品/服務、類型、應用、最終用途、地區 - 產業預測,2024-2031

Microarray Market Size, Share, Growth Analysis, By Product and Services (Consumables, Instruments), By Type (DNA Microarray, Protein Microarray), By Application, By End, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球微陣列市場規模為51億美元,從2023年的54.9億美元成長到2031年的99.4億美元,複合年成長率預計為7.7%。

微陣列技術在基因組學領域發揮著重要作用,透過將大量核酸附著在表面上,透過雜合反應來測量相對核酸序列濃度。這種創新方法與染色質免疫沉澱分析法相結合,對於定量基因表現水平和識別轉錄因子結合位點特別有用。作為為生物學家提供豐富而複雜的數位資料的首批技術之一,微陣列繼續發揮重要作用。特別是,隨著原始資料和處理數據的出現,它們的重要性日益增加,這些數據支持廣泛的分析和薈萃分析。功能基因組學數據協會制定的 MIAME 標準將確保微陣列研究的高品質和一致報告,最終推動未來預測期內對微陣列技術的需求。

目錄

介紹

  • 研究目的
  • 調查範圍
  • 定義

調查方法

  • 資訊採購
  • 二手資料和主要資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 抑制因素和挑戰
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2023)
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 價格分析

微陣列市場規模:依產品/服務及複合年成長率(2024-2031)

  • 市場概況
  • 消耗品
  • 裝置
  • 軟體和服務

微陣列市場規模:按類型和複合年成長率(2024-2031)

  • 市場概況
  • DNA微陣列
  • 蛋白質微陣列
  • 其他

微陣列市場規模:依應用與複合年成長率(2024-2031)

  • 市場概況
  • 研究用途
  • 藥物發現
  • 疾病診斷
  • 其他用途

微陣列市場規模:依最終用途和複合年成長率(2024-2031)

  • 市場概況
  • 研究/學術機構
  • 製藥和生物技術公司
  • 診斷實驗室

微陣列市場規模:按地區和複合年成長率(2024-2031)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東/非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲

競爭資訊

  • 前5名企業對比
  • 主要企業市場定位(2023年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2023)
  • 主要企業簡介
    • 公司簡介
    • 產品系列分析
    • 按細分市場分類的佔有率分析
    • 收益與前一年同期比較(2021-2023)

主要企業簡介

  • Illumina, Inc.(USA)
  • Agilent Technologies, Inc.(USA)
  • Thermo Fisher Scientific, Inc.(USA)
  • Merck KGaA(Germany)
  • PerkinElmer, Inc.(USA)
  • Arrayit Corporation(USA)
  • Bio-Rad Laboratories, Inc.(USA)
  • GE Healthcare(UK)
  • Molecular Devices, LLC.(USA)
  • Affymetrix(USA)
  • RayBiotech Life, Inc.(USA)
  • Full Moon BioSystem, Inc.(USA)
  • CapitalBio Technology Co., Ltd.(China)
  • Microarray Inc.(USA)
  • QIAGEN(Netherlands)
  • Roche NimbleGen(USA)
  • Applied Microarrays(USA)
  • bioMerieux SA(France)
  • Discerna(USA)
  • Gyros AB(Sweden)

結論和建議

簡介目錄
Product Code: SQMIG35A2595

Global Microarray Market size was valued at USD 5.1 billion in 2022 and is poised to grow from USD 5.49 billion in 2023 to USD 9.94 billion by 2031, growing at a CAGR of 7.7% during the forecast period (2024-2031).

Microarray technology remains pivotal in the genomics landscape, allowing for the binding of numerous nucleic acids to a surface, which facilitates the measurement of relative nucleic acid sequence concentrations through hybridization. This innovative approach is particularly valuable for quantifying gene expression levels and pinpointing transcription factor binding sites when paired with chromatin immunoprecipitation. As one of the earliest technologies offering biologists a wealth of complex digital data, microarrays continue to play a crucial role, especially with the advent of raw and processed data that supports extensive analysis and meta-analyses. The MIAME standards established by the Function Genomics Data Society ensure high-quality, consistent reporting in microarray research, ultimately driving demand for microarray technology in the upcoming forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microarray market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microarray Market Segmental Analysis

Global Microarray Market is segmented by product and services, type, application, end use and region. Based on product and services, the market is segmented into consumables, instruments and software and services. Based on type, the market is segmented into DNA microarray, protein microarray and others. Based on application, the market is segmented into research applications, drug discovery, disease diagnostics and others applications. Based on end use, the market is segmented into research and academic institutes, pharmaceutical and biotechnology companies and diagnostic laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microarray Market

Global Microarray is a cutting-edge technology designed for high-throughput analysis of gene expression, enabling researchers to investigate the complexities of genomic data rapidly and efficiently. This driver provides an interface for seamless integration with existing bioinformatics pipelines, allowing users to preprocess, analyze, and visualize microarray data effortlessly. With its intuitive functionality, users can easily load raw data, apply normalization techniques, perform differential expression analysis, and generate insightful visualizations such as heatmaps and volcano plots. Furthermore, the driver supports various data formats and harmonizes with popular statistical packages, ensuring compatibility and fostering reproducibility in genetic research and clinical studies.

Restraints in the Global Microarray Market

Global Microarray is a powerful biotechnology company leveraging cutting-edge microarray technology for genomic analysis. However, its expansion is restrained by several factors, including regulatory hurdles associated with genetic testing and data privacy concerns. Furthermore, the high cost of microarray technology can limit accessibility for smaller laboratories and institutions, potentially stifling research innovation. The competitive landscape, with rapid advancements in alternative genomic sequencing technologies, poses an additional challenge to maintaining market leadership. Lastly, the reliance on skilled personnel and specialized training necessitates a continuous investment in human resources, which can strain operational budgets and affect long-term sustainability.

Market Trends of the Global Microarray Market

The global microarray market is experiencing dynamic trends driven by the need for personalized medicine and precision diagnostics. As the demand for genetic analysis and profiling escalates, advancements in genomics research and understanding of genetic variations are propelling microarray technology to the forefront. Additionally, the industry is witnessing a significant shift toward multiplexing and high-throughput analysis, allowing researchers to evaluate thousands of genes or proteins simultaneously, thereby enhancing efficiency and reducing costs. Furthermore, the focus on biomarker discovery and validation is intensifying, as microarrays play a crucial role in identifying potential biomarkers for early disease detection and targeted therapies, further propelling market growth.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Microarray Market Size by Product and Services & CAGR (2024-2031)

  • Market Overview
  • Consumables
  • Instruments
  • Software and Services

Global Microarray Market Size by Type & CAGR (2024-2031)

  • Market Overview
  • DNA Microarray
  • Protein Microarray
  • Others

Global Microarray Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Research Applications
  • Drug Discovery
  • Disease Diagnostics
  • Others Applications

Global Microarray Market Size by End Use & CAGR (2024-2031)

  • Market Overview
  • Research and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Laboratories

Global Microarray Market Size & CAGR (2024-2031)

  • North America (Product and Services, Type, Application, End Use)
    • USA
    • Canada
  • Europe (Product and Services, Type, Application, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product and Services, Type, Application, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product and Services, Type, Application, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product and Services, Type, Application, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Illumina, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arrayit Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molecular Devices, LLC. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Affymetrix (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RayBiotech Life, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Full Moon BioSystem, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CapitalBio Technology Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microarray Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche NimbleGen (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Applied Microarrays (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Discerna (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gyros AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations